BKYI stock news
This page provides real-time market news, earnings updates, and company announcements related to BIO-key International, Inc. (BKYI).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-20 19:29 EST
Fusion Fuel (HTOO) Highlights Royal Uranium's Cameco-Operated Uranium Royalty (2.0% NSR) in Canada's Athabasca Basin
Finviz2026-03-17 12:03:50
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem
Finviz2026-03-17 12:03:55
Should You Keep Bio-Techne Shares in Your Investment Portfolio?
101 finance2026-03-17 18:09:36
BDX Shares Rise 0.85% on Earnings Beat but Rank 273rd in Volume Amid Margin Pressures
101 finance2026-03-18 00:09:33
Par Pacific: Refined Alpha in a Crude Price Downturn as Margins Expand and Buybacks Accelerate
101 finance2026-03-18 07:09:44
Transocean's 20K-psi Drilling Edge Unlocks Billions in Deepwater Growth—Is the Market Overlooking the Structural Setup?
101 finance2026-03-18 11:39:44
Kala Bio's Researgency.ai May Serve as a Crucial Foundation for the AI Transformation in Psychedelic Drug Discovery
101 finance2026-03-18 12:45:59
QTTB Gaps Up 11% Pre-Market with No Clear Catalyst
101 finance2026-03-18 12:48:50
Tevogen’s AI Initiative at FabCon Challenges Conventional Drug Discovery Framework
101 finance2026-03-18 16:51:49
Tonix's BIO-Europe Presentation: Will Enthusiasm for the Pipeline Surpass Market Doubts?
101 finance2026-03-18 23:09:48
PASG Surges 13% on Thin Volume — But No Catalyst to Back It
101 finance2026-03-19 10:30:46
Aptevo's March 31 Earnings Call Could Be the Definitive Catalyst After Thinness and Missed Guidance
101 finance2026-03-19 12:42:36
TNXP Breaks Key Resistance — But Volume Isn’t Convincing
101 finance2026-03-19 14:40:04
BGMSP Plunges 30.8% – What’s Behind the Sharp Intraday Slide?
101 finance2026-03-19 14:16:03
Q32 Bio (QTTB) Raised to Strong Buy: Key Information You Need
101 finance2026-03-19 17:03:55
Q32 Bio (QTTB) Elevated to Strong Buy: Key Information You Need
101 finance2026-03-19 17:03:55
Novartis's Atrium SpinCo: A Bold Cardiovascular Bet with Significant Risk and Reward Potential
101 finance2026-03-19 18:31:02
Zura Bio’s 2026 Critical Phase 2 Results: Market Assumes TibuSHIELD Will Succeed, Overlooks All-or-Nothing Risk
101 finance2026-03-19 20:31:10
INMB Surges 12% in Pre-Market on Thin Volume — Is This a False Break?
101 finance2026-03-20 09:01:04
Bold Therapeutics' BOLD-100 Pipeline Hinges on High-Stakes BIO-Europe Spring Deals
101 finance2026-03-20 13:21:51
Sanofi's $600M DR-0201 Bet: Market May Have Already Priced In the Pipeline Reset
101 finance2026-03-20 16:52:04
All Essential Information on Theravance Bio (TBPH) Rating Raised to Strong Buy
101 finance2026-03-20 17:06:57
MREO’s Legal Timeline and Cash Runway Create Binary Recovery Setup for Institutional Investors
101 finance2026-03-20 19:07:10
Bio Green Med Pref Drops 28.9% — What’s Behind This Sharp Decline in Healthcare?
101 finance2026-03-20 19:51:49
Par Pacific: Refined Alpha in a Crude Price Downturn as Margins Expand and Buybacks Accelerate
101 finance2026-03-18 07:09:44
Transocean's 20K-psi Drilling Edge Unlocks Billions in Deepwater Growth—Is the Market Overlooking the Structural Setup?
101 finance2026-03-18 11:39:44
Kala Bio's Researgency.ai May Serve as a Crucial Foundation for the AI Transformation in Psychedelic Drug Discovery
101 finance2026-03-18 12:45:59
QTTB Gaps Up 11% Pre-Market with No Clear Catalyst
101 finance2026-03-18 12:48:50
Tevogen’s AI Initiative at FabCon Challenges Conventional Drug Discovery Framework
101 finance2026-03-18 16:51:49
Tonix's BIO-Europe Presentation: Will Enthusiasm for the Pipeline Surpass Market Doubts?
101 finance2026-03-18 23:09:48
PASG Surges 13% on Thin Volume — But No Catalyst to Back It
101 finance2026-03-19 10:30:46
Aptevo's March 31 Earnings Call Could Be the Definitive Catalyst After Thinness and Missed Guidance
101 finance2026-03-19 12:42:36
TNXP Breaks Key Resistance — But Volume Isn’t Convincing
101 finance2026-03-19 14:40:04
BGMSP Plunges 30.8% – What’s Behind the Sharp Intraday Slide?
101 finance2026-03-19 14:16:03
Q32 Bio (QTTB) Raised to Strong Buy: Key Information You Need
101 finance2026-03-19 17:03:55
Q32 Bio (QTTB) Elevated to Strong Buy: Key Information You Need
101 finance2026-03-19 17:03:55
Novartis's Atrium SpinCo: A Bold Cardiovascular Bet with Significant Risk and Reward Potential
101 finance2026-03-19 18:31:02
Zura Bio’s 2026 Critical Phase 2 Results: Market Assumes TibuSHIELD Will Succeed, Overlooks All-or-Nothing Risk
101 finance2026-03-19 20:31:10
INMB Surges 12% in Pre-Market on Thin Volume — Is This a False Break?
101 finance2026-03-20 09:01:04
Bold Therapeutics' BOLD-100 Pipeline Hinges on High-Stakes BIO-Europe Spring Deals
101 finance2026-03-20 13:21:51
Sanofi's $600M DR-0201 Bet: Market May Have Already Priced In the Pipeline Reset
101 finance2026-03-20 16:52:04
All Essential Information on Theravance Bio (TBPH) Rating Raised to Strong Buy
101 finance2026-03-20 17:06:57
MREO’s Legal Timeline and Cash Runway Create Binary Recovery Setup for Institutional Investors
101 finance2026-03-20 19:07:10
Bio Green Med Pref Drops 28.9% — What’s Behind This Sharp Decline in Healthcare?
101 finance2026-03-20 19:51:49
BKYI stock chart
BKYI stock detailsBKYI stock price change
On the last trading day, BKYI stock closed at 0.64 USD, with a price change of -3.30% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more